David Scadden - Director at Agios Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AGIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

David Scadden - trading volume in the past year for Agios Pharmaceuticals, Inc.

Holdings reported by David Scadden for Agios Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 17.6K $772K $43.84 Nov 12, 2025 Direct
Restricted stock units 0 $104K $48.84 Jun 20, 2025 Direct Common stock
Stock options (right to buy) 26.9K Nov 12, 2025 Direct Common stock

Transactions reported by David Scadden for Agios Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.